Should You Buy Eli Lilly Stock Before June 22?

Eli Lilly (NYSE: LLY) stock hasn't been doing too well this year, but that could change later this month. A couple of key events are on the horizon this month during which the company will release new data from studies relating to multiple GLP-1 drugs. They can give investors insights into how well the drugs are doing, and whether approvals for new drugs and indications could be forthcoming in the near future.If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs. Should you invest in this top healthcare company before June 22?Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool